Find Ciprofloxacin Hydrochloride manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

USP

0

JP

GLOBAL SALES INFORMATION

Annual Reports

NA

MARKET PLACE

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Ciprofloxacin hcl, 93107-08-5, 86483-48-9, 1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid hydrochloride, Cipro, Chebi:310388
Molecular Formula
C17H19ClFN3O3
Molecular Weight
367.8  g/mol
InChI Key
DIOIOSKKIYDRIQ-UHFFFAOYSA-N
FDA UNII
0MP32MFP6C

Ciprofloxacin Hydrochloride
A broad-spectrum antimicrobial carboxyfluoroquinoline.
1 2D Structure

Ciprofloxacin Hydrochloride

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid;hydrochloride
2.1.2 InChI
InChI=1S/C17H18FN3O3.ClH/c18-13-7-11-14(8-15(13)20-5-3-19-4-6-20)21(10-1-2-10)9-12(16(11)22)17(23)24;/h7-10,19H,1-6H2,(H,23,24);1H
2.1.3 InChI Key
DIOIOSKKIYDRIQ-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O.Cl
2.2 Other Identifiers
2.2.1 UNII
0MP32MFP6C
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Anhydrous, Ciprofloxacin Hydrochloride

2. Bay 09867

3. Bay-09867

4. Bay09867

5. Ciprinol

6. Cipro

7. Ciprofloxacin

8. Ciprofloxacin Hydrochloride Anhydrous

9. Ciprofloxacin Monohydrochloride Monohydrate

10. Hydrochloride Anhydrous, Ciprofloxacin

11. Hydrochloride, Ciprofloxacin

12. Monohydrate, Ciprofloxacin Monohydrochloride

13. Monohydrochloride Monohydrate, Ciprofloxacin

2.3.2 Depositor-Supplied Synonyms

1. Ciprofloxacin Hcl

2. 93107-08-5

3. 86483-48-9

4. 1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic Acid Hydrochloride

5. Cipro

6. Chebi:310388

7. Ciprofloxacin Hydrochloride Anhydrous

8. 0mp32mfp6c

9. 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic Acid Hydrochloride

10. Ciprofloxacin (monohydrochloride)

11. Bay-o-9867

12. Ciprofloxacin Hydrochloride (anh.)

13. Bay O 9867

14. Cetraxal

15. Ciprobay

16. Ciproxan

17. Ciproxin

18. Flociprin

19. Ciflox

20. Mfcd00079044

21. 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic Acid Hcl

22. 1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic Acid;hydrochloride

23. 1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic Acid Xhydrochloride

24. Bay-o 9867

25. 93107-08-5 (hcl)

26. 1-cyclopropyl-6-fluoro-4-oxo-7-(1-piperazinyl)-1,4-dihydro-3-quinolinecarboxylic Acid Hydrochloride

27. Dsstox_cid_27768

28. Dsstox_rid_82545

29. Dsstox_gsid_47788

30. Ciprofloxacin (as Hydrochloride)

31. Prestwick_67

32. 1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-quinoline-3-carboxylic Acid; Hydrochloride

33. 4-(3-carboxy-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-quinolin-7-yl)-piperazin-1-ium; Chloride

34. Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic Acid, Monohydrochloride

35. Nsc620634

36. Ciprofloxacin Hydrochloride (anhydrous)

37. Ciprofloxacin 100 Microg/ml In Methanol

38. Ncgc00016959-01

39. Cas-93107-08-5

40. Unii-0mp32mfp6c

41. 3-quinolinecarboxylic Acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-, Hydrochloride

42. 3-quiolinecarboxylic Acid

43. Ciprofloxacine Hydrochloride

44. Epitope Id:174846

45. Cambridge Id 5807784

46. Ciprofloxacini Hydrochloridum

47. Chembl1202

48. Schembl42310

49. 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic Acid Monohydrochloride

50. 3-quinolinecarboxylic Acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-, Monohydrochloride

51. Ciprofloxacin Hcl/lactate

52. Dtxsid1047788

53. Hy-b0356a

54. Ciprofloxacin Hydrochloride (1:x)

55. Hms1568g08

56. Bcp13634

57. Bcp14336

58. Tox21_110712

59. S5008

60. Akos005111008

61. Tox21_110712_1

62. Cs-8134

63. Ks-5012

64. Nsc-620634

65. Sb73037

66. Ncgc00016959-06

67. 3-quinolinecarboxylic Acid, 1,4-dihydro-1-cyclopropyl-6-fluoro-4-oxo-7-(1-piperazinyl)-, Hydrochloride

68. Ac-23972

69. Bim-0048462.p001

70. Ciprofloxacin 1000 Microg/ml In Methanol

71. Ciprofloxacin Hydrochloride [who-dd]

72. Ft-0623850

73. Ft-0623851

74. A16969

75. H10663

76. A859872

77. Q-200860

78. Q27105154

79. F0001-2378

80. Cpx; Cetraxal; Ciloxan; Cipro; Bay-09867 Hydrochloride

81. 1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic Acid Hcl

82. 1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylicacidxhydrochloride

83. 3-quinolinecarboxylic Acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-, Hydrochloride (1:1)

2.4 Create Date
2005-03-26
3 Chemical and Physical Properties
Molecular Weight 367.8 g/mol
Molecular Formula C17H19ClFN3O3
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count7
Rotatable Bond Count3
Exact Mass367.1098973 g/mol
Monoisotopic Mass367.1098973 g/mol
Topological Polar Surface Area72.9 Ų
Heavy Atom Count25
Formal Charge0
Complexity571
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Drug and Medication Information
4.1 Drug Information
1 of 2  
Drug NameCiprofloxacin hydrochloride
PubMed HealthCiprofloxacin Betaine/Ciprofloxacin Hydrochloride (By mouth)
Drug ClassesAntibacterial
Drug LabelCiprofloxacin Tablets, USPis a synthetic broad spectrum antimicrobial agent for oral administration. Ciprofloxacin hydrochloride, USP, a fluoroquinolone, is the monohydrochloride monohydrate salt of 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-pip...
Active IngredientCiprofloxacin hydrochloride
Dosage FormSolution/drops; Tablet
RouteOphthalmic; Oral
Strengtheq 100mg base; eq 750mg base; eq 500mg base; eq 0.3% base; eq 250mg base
Market StatusPrescription
CompanyWatson Labs; Nexus Pharms; Ranbaxy; Ivax Sub Teva Pharms; Apotex; Bausch And Lomb; Aurobindo Pharma; Taro; Dr Reddys Labs; Unique Pharm Labs; Carlsbad; Pharmaforce; Fdc; Mylan; Hikma; Akorn

2 of 2  
Drug NameCiprofloxacin hydrochloride
PubMed HealthCiprofloxacin Betaine/Ciprofloxacin Hydrochloride (By mouth)
Drug ClassesAntibacterial
Drug LabelCiprofloxacin Tablets, USPis a synthetic broad spectrum antimicrobial agent for oral administration. Ciprofloxacin hydrochloride, USP, a fluoroquinolone, is the monohydrochloride monohydrate salt of 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-pip...
Active IngredientCiprofloxacin hydrochloride
Dosage FormSolution/drops; Tablet
RouteOphthalmic; Oral
Strengtheq 100mg base; eq 750mg base; eq 500mg base; eq 0.3% base; eq 250mg base
Market StatusPrescription
CompanyWatson Labs; Nexus Pharms; Ranbaxy; Ivax Sub Teva Pharms; Apotex; Bausch And Lomb; Aurobindo Pharma; Taro; Dr Reddys Labs; Unique Pharm Labs; Carlsbad; Pharmaforce; Fdc; Mylan; Hikma; Akorn

4.2 Drug Indication

Treatment of chronic pulmonary infections caused by Pseudomonas aeruginosa


5 Pharmacology and Biochemistry
5.1 MeSH Pharmacological Classification

Anti-Bacterial Agents

Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)


Topoisomerase II Inhibitors

Compounds that inhibit the activity of DNA TOPOISOMERASE II. Included in this category are a variety of ANTINEOPLASTIC AGENTS which target the eukaryotic form of topoisomerase II and ANTIBACTERIAL AGENTS which target the prokaryotic form of topoisomerase II. (See all compounds classified as Topoisomerase II Inhibitors.)


Cytochrome P-450 CYP1A2 Inhibitors

Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 CYP1A2. (See all compounds classified as Cytochrome P-450 CYP1A2 Inhibitors.)


5.2 FDA Pharmacological Classification
5.2.1 Pharmacological Classes
Quinolones [CS]; Quinolone Antimicrobial [EPC]

DRUG PRODUCT COMPOSITIONS

Do you need Business Intel? Ask us

DOSAGE - SOLUTION/DROPS;OPHTHALMIC - EQ 0.3% ...DOSAGE - SOLUTION/DROPS;OPHTHALMIC - EQ 0.3% BASE

USFDA APPLICATION NUMBER - 19992

read-more

DOSAGE - OINTMENT;OPHTHALMIC - EQ 0.3% BASE

USFDA APPLICATION NUMBER - 20369

read-more

DOSAGE - SUSPENSION/DROPS;OTIC - EQ 0.2% BASE...DOSAGE - SUSPENSION/DROPS;OTIC - EQ 0.2% BASE;1%

USFDA APPLICATION NUMBER - 20805

read-more

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Fillers, Diluents & Binders

read-more
read-more

Coating Systems & Additives

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Direct Compression

read-more
read-more

Solubilizers

read-more
read-more

Granulation

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Parenteral

read-more
read-more

Controlled & Modified Release

read-more
read-more

Topical

read-more
read-more

Taste Masking

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Lubricants & Glidants

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Co-Processed Excipients

read-more
read-more

Emulsifying Agents

read-more
read-more

API Stability Enhancers

read-more
read-more

Surfactant & Foaming Agents

read-more
read-more

Empty Capsules

read-more
read-more

Rheology Modifiers

read-more
read-more

Vegetarian Capsules

read-more
read-more

Coloring Agents

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Looking for 86483-48-9 / Ciprofloxacin Hydrochloride API manufacturers, exporters & distributors?

Ciprofloxacin Hydrochloride manufacturers, exporters & distributors 1

25

PharmaCompass offers a list of Ciprofloxacin Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ciprofloxacin Hydrochloride manufacturer or Ciprofloxacin Hydrochloride supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ciprofloxacin Hydrochloride manufacturer or Ciprofloxacin Hydrochloride supplier.

PharmaCompass also assists you with knowing the Ciprofloxacin Hydrochloride API Price utilized in the formulation of products. Ciprofloxacin Hydrochloride API Price is not always fixed or binding as the Ciprofloxacin Hydrochloride Price is obtained through a variety of data sources. The Ciprofloxacin Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Ciprofloxacin Hydrochloride

Synonyms

Ciprofloxacin hcl, 93107-08-5, 86483-48-9, 1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid hydrochloride, Cipro, Chebi:310388

Cas Number

86483-48-9

Unique Ingredient Identifier (UNII)

0MP32MFP6C

About Ciprofloxacin Hydrochloride

A broad-spectrum antimicrobial carboxyfluoroquinoline.

Ciprofloxacin Monohydrochloride Monohydrate Manufacturers

A Ciprofloxacin Monohydrochloride Monohydrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ciprofloxacin Monohydrochloride Monohydrate, including repackagers and relabelers. The FDA regulates Ciprofloxacin Monohydrochloride Monohydrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ciprofloxacin Monohydrochloride Monohydrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Ciprofloxacin Monohydrochloride Monohydrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Ciprofloxacin Monohydrochloride Monohydrate Suppliers

A Ciprofloxacin Monohydrochloride Monohydrate supplier is an individual or a company that provides Ciprofloxacin Monohydrochloride Monohydrate active pharmaceutical ingredient (API) or Ciprofloxacin Monohydrochloride Monohydrate finished formulations upon request. The Ciprofloxacin Monohydrochloride Monohydrate suppliers may include Ciprofloxacin Monohydrochloride Monohydrate API manufacturers, exporters, distributors and traders.

click here to find a list of Ciprofloxacin Monohydrochloride Monohydrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Ciprofloxacin Monohydrochloride Monohydrate USDMF

A Ciprofloxacin Monohydrochloride Monohydrate DMF (Drug Master File) is a document detailing the whole manufacturing process of Ciprofloxacin Monohydrochloride Monohydrate active pharmaceutical ingredient (API) in detail. Different forms of Ciprofloxacin Monohydrochloride Monohydrate DMFs exist exist since differing nations have different regulations, such as Ciprofloxacin Monohydrochloride Monohydrate USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Ciprofloxacin Monohydrochloride Monohydrate DMF submitted to regulatory agencies in the US is known as a USDMF. Ciprofloxacin Monohydrochloride Monohydrate USDMF includes data on Ciprofloxacin Monohydrochloride Monohydrate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Ciprofloxacin Monohydrochloride Monohydrate USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Ciprofloxacin Monohydrochloride Monohydrate suppliers with USDMF on PharmaCompass.

Ciprofloxacin Monohydrochloride Monohydrate JDMF

The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

The Ciprofloxacin Monohydrochloride Monohydrate Drug Master File in Japan (Ciprofloxacin Monohydrochloride Monohydrate JDMF) empowers Ciprofloxacin Monohydrochloride Monohydrate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

PMDA reviews the Ciprofloxacin Monohydrochloride Monohydrate JDMF during the approval evaluation for pharmaceutical products. At the time of Ciprofloxacin Monohydrochloride Monohydrate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

click here to find a list of Ciprofloxacin Monohydrochloride Monohydrate suppliers with JDMF on PharmaCompass.

Ciprofloxacin Monohydrochloride Monohydrate KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a Ciprofloxacin Monohydrochloride Monohydrate Drug Master File in Korea (Ciprofloxacin Monohydrochloride Monohydrate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Ciprofloxacin Monohydrochloride Monohydrate. The MFDS reviews the Ciprofloxacin Monohydrochloride Monohydrate KDMF as part of the drug registration process and uses the information provided in the Ciprofloxacin Monohydrochloride Monohydrate KDMF to evaluate the safety and efficacy of the drug.

After submitting a Ciprofloxacin Monohydrochloride Monohydrate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Ciprofloxacin Monohydrochloride Monohydrate API can apply through the Korea Drug Master File (KDMF).

click here to find a list of Ciprofloxacin Monohydrochloride Monohydrate suppliers with KDMF on PharmaCompass.

Ciprofloxacin Monohydrochloride Monohydrate CEP

A Ciprofloxacin Monohydrochloride Monohydrate CEP of the European Pharmacopoeia monograph is often referred to as a Ciprofloxacin Monohydrochloride Monohydrate Certificate of Suitability (COS). The purpose of a Ciprofloxacin Monohydrochloride Monohydrate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Ciprofloxacin Monohydrochloride Monohydrate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Ciprofloxacin Monohydrochloride Monohydrate to their clients by showing that a Ciprofloxacin Monohydrochloride Monohydrate CEP has been issued for it. The manufacturer submits a Ciprofloxacin Monohydrochloride Monohydrate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Ciprofloxacin Monohydrochloride Monohydrate CEP holder for the record. Additionally, the data presented in the Ciprofloxacin Monohydrochloride Monohydrate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Ciprofloxacin Monohydrochloride Monohydrate DMF.

A Ciprofloxacin Monohydrochloride Monohydrate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Ciprofloxacin Monohydrochloride Monohydrate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.

click here to find a list of Ciprofloxacin Monohydrochloride Monohydrate suppliers with CEP (COS) on PharmaCompass.

Ciprofloxacin Monohydrochloride Monohydrate WC

A Ciprofloxacin Monohydrochloride Monohydrate written confirmation (Ciprofloxacin Monohydrochloride Monohydrate WC) is an official document issued by a regulatory agency to a Ciprofloxacin Monohydrochloride Monohydrate manufacturer, verifying that the manufacturing facility of a Ciprofloxacin Monohydrochloride Monohydrate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Ciprofloxacin Monohydrochloride Monohydrate APIs or Ciprofloxacin Monohydrochloride Monohydrate finished pharmaceutical products to another nation, regulatory agencies frequently require a Ciprofloxacin Monohydrochloride Monohydrate WC (written confirmation) as part of the regulatory process.

click here to find a list of Ciprofloxacin Monohydrochloride Monohydrate suppliers with Written Confirmation (WC) on PharmaCompass.

Ciprofloxacin Monohydrochloride Monohydrate NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Ciprofloxacin Monohydrochloride Monohydrate as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Ciprofloxacin Monohydrochloride Monohydrate API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Ciprofloxacin Monohydrochloride Monohydrate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Ciprofloxacin Monohydrochloride Monohydrate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Ciprofloxacin Monohydrochloride Monohydrate NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Ciprofloxacin Monohydrochloride Monohydrate suppliers with NDC on PharmaCompass.

Ciprofloxacin Monohydrochloride Monohydrate GMP

Ciprofloxacin Monohydrochloride Monohydrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Ciprofloxacin Monohydrochloride Monohydrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ciprofloxacin Monohydrochloride Monohydrate GMP manufacturer or Ciprofloxacin Monohydrochloride Monohydrate GMP API supplier for your needs.

Ciprofloxacin Monohydrochloride Monohydrate CoA

A Ciprofloxacin Monohydrochloride Monohydrate CoA (Certificate of Analysis) is a formal document that attests to Ciprofloxacin Monohydrochloride Monohydrate's compliance with Ciprofloxacin Monohydrochloride Monohydrate specifications and serves as a tool for batch-level quality control.

Ciprofloxacin Monohydrochloride Monohydrate CoA mostly includes findings from lab analyses of a specific batch. For each Ciprofloxacin Monohydrochloride Monohydrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Ciprofloxacin Monohydrochloride Monohydrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Ciprofloxacin Monohydrochloride Monohydrate EP), Ciprofloxacin Monohydrochloride Monohydrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ciprofloxacin Monohydrochloride Monohydrate USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty